Prosecution Insights
Last updated: August 17, 2026

Examiner: SEAMAN, D MARGARET M

Tech Center 1600 • Art Units: 1625 1629 1691

This examiner grants 77% of resolved cases

Performance Statistics

76.6%
Allow Rate
+16.6% vs TC avg
1,420
Total Applications
+8.0%
Interview Lift
797
Avg Prosecution Days
Based on 1398 resolved cases, 2023–2026

Rejection Statute Breakdown

4.5%
§101 Eligibility
19.6%
§102 Novelty
15.9%
§103 Obviousness
36.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18708499 COMPOSITIONS COMPRISING AMINO LIPID COMPOUNDS AND METHODS OF MAKING AND USE THEREOF Non-Final OA Ohio State Innovation Foundation
17998911 METHODS FOR THE TREATMENT OF PANCREATITIS AND PREVENTION OF PANCREATIC CANCER Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
18829953 QUINOLINE cGAS ANTAGONIST COMPOUNDS Non-Final OA THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
17962656 Toll-Like Receptor 8 (TLR8)-Specific Antagonists and Methods of Making and Uses Thereof Final Rejection The Regents of the University of Colorado, a body corporate

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month